Clinical Trial Update: Alpha-lipoic Acid in Diabetic Nephropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating alpha-lipoic acid for Type 1 diabetes (diabetic nephropathy). Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Ain Shams University | Conditions: Type 1 Diabetes | Phase 3 | Status: UNKNOWN